Configuration of medical device system for impedance-based calibration of dialysis session

Through the collection and use of machine learning models of physiological parameter data analyzed by implantable medical devices, the user intervention and risk assessment problems in dialysis treatment are solved, and the safety and efficiency of dialysis treatment are improved.

CN119031881APending Publication Date: 2024-11-26MEDTRONIC INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380034529.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-04-22
Filing Date
2023-04-14
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

Existing medical systems are difficult to effectively reduce user intervention in dialysis treatment, especially when physicians cannot accompany patients continuously, and it is difficult to accurately evaluate and control risks during dialysis, resulting in possible adverse events such as arrhythmia or death.

Method used

Implanted medical device (IMD) continuously collects physiological parameter data, including impedance data in the blood vessels, predicts the risk level of the dialysis process through machine learning models, and generates output data for clinician reference to guide the adjustment and control of dialysis treatments. .

Benefits of technology

By reducing user intervention during dialysis, improve the safety and efficiency of dialysis treatment, reduce patient risks, and enhance the accuracy and safety of dialysis treatment, especially when physicians cannot monitor continuously.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119031881A_ABST
    Figure CN119031881A_ABST
Patent Text Reader

Abstract

The present disclosure relates to medical systems and techniques for providing enhanced care to a patient by implementing dialysis management. In one example medical system configured for dialysis treatment, a computing device may be configured to perform a risk assessment on a patient about to perform a dialysis session based on impedance data. In other examples, the computing device may be configured to accurately estimate a fluid volume using the impedance data for controlling an amount of fluid to be removed during the dialysis session.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application claims the benefit of U.S. Provisional Patent Application Serial No. 63 / 363,457, filed on April 22, 2022, the entire contents of which are incorporated herein by reference. Technical Field

[0002] The present disclosure relates generally to medical systems, and more particularly to medical systems configured for use in medical procedures that provide cardiovascular and / or renal care to patients. Background Art

[0003] Medical professionals may use medical systems on their patients for a variety of reasons, such as having the medical system record patient data for future use and / or perform procedures to treat health events / diseases (e.g., through dialysis). Some medical professionals rely on medical systems to provide the best medical care for their patients, and these patients may receive medical care from the medical system at home and / or at a hospital or another health care facility. For various purposes, medical professionals may program the medical system to operate as needed, which may be based on specific algorithms and / or configurable settings. Some example operations use patient data to calibrate medical system components to detect health events / diseases, deliver therapy in the form of conventional treatments, and the like.

[0004] A medical system may monitor various types of data from a patient or a group of patients for one or more purposes. In numerous examples, some medical systems may record measurements of a patient and his or her heart as an indicator of the patient's heart health. Other medical systems provide dialysis as a treatment for renal failure (including acute renal failure) for a short period of time until the patient's kidneys improve, or for the remainder of the patient's life in the case of chronic or end-stage renal failure. Dialysis refers to the classification of medical procedures that remove urea, toxins, water, and / or electrolytes from a patient's body. Some of these medical systems specialize in performing one or more medical procedures in a dialysis subclassification (such as ultrafiltration), which removes sodium and water from a patient's body. Dialysis (including ultrafiltration) can improve the hemodynamics of patients with heart failure (HF). Summary of the invention

[0005] Medical systems and techniques as described herein facilitate protocols corresponding to, for example, dialysis treatments for patients with renal failure or HF. In general, these systems and techniques advantageously use one or more medical devices of a patient as an impedance measurement mechanism to guide a clinician or patient in performing a dialysis session or instruct a dialysis system to perform a dialysis session, thereby advantageously reducing or eliminating user intervention.

[0006] Various medical devices (e.g., implantable devices, wearable devices, etc.) can be configured to monitor and collect data related to patient physiology, and detect changes in patient health associated with changes in the data recording the patient's physiology. Some of the collected data include impedance data of fluids (e.g., blood) and / or tissues. The patient's physician can initiate a dialysis course for the patient, where the dialysis system's computing device uses impedance data as a substitute for fluid volume information (e.g., measurements). At a minimum, the medical system described herein assists physicians in conducting a dialysis course (or another medical procedure for removing unwanted fluids from the body), and in some cases, enables technology to avoid patient harm (e.g., cardiac arrhythmia or death), for example, by assessing / reducing patient risk.

[0007] In view of the foregoing, the present disclosure describes technical improvements and / or technical solutions integrated into at least one practical application, as the medical systems and techniques described herein enhance dialysis treatment through informed risk assessment, thereby mitigating or entirely eliminating problems associated with using the current set of dialysis parameters, such as when physicians lack direct impedance measurements of the intravascular space.

[0008] The technology of the present disclosure can be implemented by systems including one or more IMDs, and these systems can autonomously and continuously collect physiological parameter data while the IMD is implanted in the patient for months or years, and perform a large number of operations on the data per second to enable the system herein to determine risk levels or other data that can be used to control dialysis procedures. The technology of the present disclosure can be used with IMDs when the physician is unable to continuously accompany the patient between dialysis sessions to assess physiological parameters and / or when performing operations on the data described herein is considered by the physician to be practically impossible to perform.

[0009] In some examples, the techniques and systems of the present disclosure may use a machine learning model to more accurately determine the risk level of a dialysis procedure or otherwise infer a patient's condition based on physiological data collected by an IMD for use in determining parameters of a dialysis procedure. In some examples, a machine learning model is trained using a set of training instances, wherein one or more of the training instances include data indicating the relationship between each set of input data and the output. Because the machine learning model is trained with potentially thousands or millions of training instances, the machine learning model may reduce the amount of error in the risk level or other values ​​useful for dialysis control. Reducing errors using the techniques of the present disclosure may provide one or more technical and clinical advantages, such as increasing dialysis efficacy and patient safety.

[0010] In one example, a medical system includes: one or more medical devices configured to collect physiological parameter data of a patient, wherein the physiological parameter data includes impedance data corresponding to at least one fluid volume in the patient; and processing circuitry configured to: determine a dry impedance of the patient undergoing a dialysis treatment based on the physiological parameter data; and generate output data indicative of the dry impedance for presentation to a clinician.

[0011] In another example, a medical system includes: one or more medical devices configured to collect physiological parameter data of a patient, wherein the physiological parameter data includes impedance data corresponding to at least one fluid volume in the patient's body; and processing circuitry configured to: determine a risk level of the patient for receiving a dialysis treatment based on the physiological parameter data; and generate output data indicating the risk level for presentation to a clinician.

[0012] In another example, a method is described in which a processing circuit of a medical system is executed, the medical system having one or more medical devices configured to collect physiological parameter data of a patient. The method includes: determining a risk level of the patient receiving a dialysis course based on the physiological parameter data, wherein the physiological parameter data includes impedance data corresponding to at least one fluid volume in the patient; and generating output data indicating the risk level for presentation to a clinician.

[0013] The present disclosure is intended to provide an overview of the subject matter described in the present disclosure. The present disclosure is not intended to provide an exclusive or exhaustive explanation of the systems, devices, and methods described in detail in the following figures and description. Further details of one or more examples of the present disclosure are set forth in the following figures and description. Other features, objectives, and advantages will be apparent from the description and drawings, as well as from the claims. BRIEF DESCRIPTION OF THE DRAWINGS

[0014] Figure 1A An example environment of an example medical system in conjunction with a patient according to one or more examples of the present disclosure is illustrated.

[0015] Figure 1B An example of a method including multiple implantable medical devices according to one or more examples of the present disclosure is illustrated. Figure 1A An example configuration of an example medical device system in.

[0016] Figure 2 One or more examples of the present disclosure are illustrated. Figure 1A A block diagram of an example configuration of a medical device.

[0017] Figure 3One or more examples of the present disclosure are illustrated. Figure 1A A block diagram of an example configuration of an external device.

[0018] Figure 4 is a block diagram illustrating an example system according to one or more examples of the present disclosure, the example system including an access point, a network, an external computing device (such as a server), and one or more other computing devices that can be coupled to FIG. 1 through FIG. Figure 3 Medical devices and external devices.

[0019] Figure 5 is a flow diagram illustrating example operations according to one or more examples of the present disclosure.

[0020] Figure 6 is a flow chart illustrating another example operation according to one or more examples of the present disclosure.

[0021] Figure 7 is an illustration of a graph of a dynamic dialysis calibration according to one or more examples of the present disclosure.

[0022] Figure 8 is a conceptual diagram illustrating an example machine learning model configured to determine one or more of a dialysis parameter, a target dry weight, a fluid volume, or a risk of a dialysis session based on impedance measurements.

[0023] Fig. 9 is a conceptual diagram illustrating an example training process for an artificial intelligence model according to an example of the present disclosure.

[0024] Fig. 10A is a perspective view illustrating an example IMD.

[0025] Fig. 10B is a perspective view illustrating another example IMD.

[0026] Like reference characters represent like elements throughout the specification and drawings. DETAILED DESCRIPTION

[0027] Generally speaking, a medical system according to the present disclosure implements techniques for guiding a dialysis session based on physiological parameters measured by an implantable medical device (IMD), such as impedance measured by a subcutaneously inserted cardiac monitoring device. In some examples, the medical system performs a risk assessment as part of or in preparation for a dialysis session.

[0028] Figure 1A The environment of an example medical system 2 in conjunction with a patient 4 is illustrated in accordance with one or more techniques of the present disclosure. In addition to one or more patient computing devices 6 (such as Figure 1AIn addition to computing devices 6A and 6B illustrated in the drawings, physician 8 of patient 4 may also access data provided by IMD 10 via external device 12. Example techniques may be used with computing devices such as external device 12 or one or more patient computing devices 6 that may be used with IMD 10, dialysis system 14, and / or Figure 1A The computing devices 6 and 12 may also be communicatively coupled to at least one of an electronic health record (EHR) 18 and / or a computing system 20 via a network 16.

[0029] IMD 10 (which can communicate with at least one external computing device and / or Figure 1A 10 is an example medical device inserted into the body of patient 4 by physician 8 of patient 4. In some examples, IMD 10 is implanted outside the chest of patient 4 (e.g., implanted subcutaneously). Figure 1A ). The IMD 10 may be positioned near the sternum or just below the level of the heart of the patient 4, for example, at least partially within the outline of the heart. The IMD 10 includes a plurality of electrodes ( Figure 1A 10 is a device that is not shown in the figure and is configured to sense cardiac EGM via a plurality of electrodes. In some examples, the IMD 10 employs the Reveal LINQ available from Medtronic, Inc. of Minneapolis, MN. TM or LINQ II TM In the form of an Insertable Cardiac Monitor (ICM).

[0030] External device 12, which may be referred to as a physician device, may be a computing device having a display viewable by a user and an interface for receiving user input to external device 12. In some examples, external device 12 may be a laptop computer, a tablet computer, a workstation, one or more servers, a cellular phone, a personal digital assistant, or another computing device that may run an application that enables the computing device to interact with IMD 10 and / or dialysis system 14.

[0031] External device 12 is configured to communicate with patient computing device 6, IMD 10, dialysis system 14, and optionally with another computing device (not illustrated in FIG. 1 ) via wireless communications. External device 12 may communicate with patient computing device 6, IMD 10, dialysis system 14, and optionally with another computing device (not illustrated in FIG. 1 ), for example, via near field communication technology (e.g., inductive coupling, NFC, or other communication technology that may operate at a range of less than 10 cm to 20 cm) and far field communication technology (e.g., compliant with 802.11 or 802.14). The wireless communication system may communicate using radio frequency (RF) telemetry or other communication technologies that may operate at a range greater than near field communication technologies.

[0032] External device 12 may be used to configure device settings and / or operating parameters of dialysis system 14. External device 12 may be a dedicated device for enabling the physician to control dialysis system 14 and its performance of dialysis treatments for patient 4, e.g., by modifying various ones of such settings and / or parameters, as directed by physician 8 (e.g., a programmer for dialysis system 14). In some examples, external device 12 may be an off-the-shelf computing device (e.g., a tablet computer) with dedicated software for the techniques described herein.

[0033] The external device 12 may be used to retrieve data from the IMD 10, for example, directly or via the computing device 6. In some examples, the retrieved data may include sensor data (e.g., electrocardiogram (ECG) data) indicating electrical activity of the heart of the patient 4. In some examples, the retrieved data may include values ​​of sensor data, the sensor data including various impedance data, including impedance measurements of the intravascular space, the extravascular space, and / or the interstitial space. An additional medical device may provide sensor data including impedance measurements to the external device 12. An example of such a device may be an ICM configured to measure the impedance of the interstitial space. Additional details of the ICM are provided in U.S. Patent Application Publication No. 2017 / 0273589 (filed on March 25, 2016 and assigned to U.S. Patent Application Serial No. 15 / 081,216), the entire contents of which are incorporated herein by reference.

[0034] The external device 12 may be used to determine the net filtration rate based on impedance measurements of the interstitial space and impedance measurements of the intravascular space for an interdialytic period between a dialysis session and a previous dialysis session and / or an intradialytic period during a dialysis session. In other examples, the external device 12 may be used to determine the net filtration rate based on impedance measurements of the interstitial space and / or physiological parameter data of another physiological parameter indicative of fluid volume in the intravascular space. The other physiological parameters include at least one of an electrocardiogram morphology parameter or a heart sound parameter. The external device 12 may be configured to output the net filtration rate for presentation to a clinician when determining a risk level based on the net filtration rate and / or to generate dialysis parameter data for controlling a dialysis session based on the net filtration rate.

[0035] The sensor data includes sensor signals (e.g., raw sensor data) and / or physiological / diagnostic attributes (e.g., processed sensor data). Some or all of the sensor data may be classified as impedance data or non-impedance data. Examples of non-impedance data may include, but are not limited to, patient profile / medical history (e.g., arrhythmia history), heart rate data (e.g., cardiac measurements and heart rate variability (HRV)), patient activity data (e.g., accelerometer data, posture data, etc.), patient posture data, medical device history (e.g., log) of detected health events (e.g., cardiac events, such as premature ventricular contractions (PVCs)), etc. As explained in further detail below, some or all examples of non-impedance data may be inputs to the dialysis system 14, such as respiratory rate, posture data perfusion information, ambulatory blood pressure (ABP) results, potassium estimates, etc. Other examples of non-impedance data may include electrocardiogram data recorded by the IMD 10 (e.g., heart EGM segments with timestamps).

[0036] Processing circuitry of medical system 2 (e.g., processing circuitry of one or more devices of computing system 20, IMD 10, computing device 6, external device 12, and / or one or more other computing devices) may be configured to perform the techniques described herein. Processing circuitry of medical system 2 may employ various known mechanisms to capture various examples (e.g., samples) of sensor data and generate information representative of fluid volume, and in some cases, information representative of the physiological effects of changes in fluid volume over a period of time. Electrodes of IMD 10 may operate as impedance measurement devices for dialysis system 14.

[0037] The present disclosure describes a variety of techniques for using any of the above-mentioned examples of impedance data and physiological / diagnostic attributes. In one example, the processing circuitry of the medical system 2 may be configured to perform a risk assessment for an upcoming dialysis course that the patient 4 is scheduled / prepared to receive. There are a variety of techniques for performing a risk assessment, in which the probability (e.g., likelihood) of an adverse event occurring during or as a result of an upcoming dialysis course is determined. The processing circuitry of the medical system 2 may execute example techniques for implementing a machine learning / artificial intelligence mechanism to determine the above-mentioned probability. To illustrate by way of example, the processing circuitry of the medical system 2 may generate a machine learning model by training a multivariate mathematical function or probability distribution to predict the likelihood of an adverse outcome from an upcoming dialysis course. One or more model parameters may correspond to a fluid volume calculation based on impedance measurements and / or other physiological parameters. In other examples, the machine learning model may be configured to determine initial or updated dialysis parameters for a dialysis system as described herein.

[0038] The dialysis system 14 is described herein as a medical device used by a physician 8 to provide dialysis therapy to a patient 4, which dialysis therapy includes a planned dialysis course for a limited period of time or for the remainder of the life of the patient 4. In one example, the dialysis system 14 may perform the steps of a medical procedure to remove unwanted / excess fluids (e.g., fluid components such as water, sodium, potassium, etc.) and toxins from the body (e.g., blood) of the patient 4 when performing the example dialysis course. In the further execution of the example dialysis course, the dialysis system 14 may perform one or more steps to return the remaining fluid components (e.g., blood) to the body of the patient 4. As part of the medical procedure, the dialysis system 14 may exchange information with the external device 12 and, for example, provide additional physiological / diagnostic attributes, such as current weight, blood pressure, other safety measures. Given the nature of the medical procedure, the area 24 may represent a medical facility (e.g., a clinic or hospital) where a patient similar to the patient 4 routinely receives dialysis courses. Alternatively, the area 24 may represent the home or residence of the patient 4.

[0039] The external device 12 may retrieve sensor data to perform a risk assessment on the patient 4 and / or determine an intradialytic fluid volume estimate and / or an interdialytic fluid volume estimate using impedance data (e.g., measurements) recorded during the interdialytic period between dialysis sessions (which may be referred to as dry impedance and / or wet impedance, respectively).

[0040] The external device 12 may retrieve non-impedance data including posture data from the IMD 10 and possibly from other devices attached to or inserted into the patient 4. In some examples, the external device 12 may retrieve posture data and incorporate the data into the impedance fluid monitoring function. Having information (e.g., non-impedance data) at or before and after recording impedance data may enhance the fluid volume estimation (e.g., in terms of accuracy) and / or risk level assessment of the processing circuitry of the medical system 2. Such information would include posture data, such as indicating what posture (e.g., position) the patient 4 was in when the IMD 10 recorded the impedance measurement and the length of time the patient 4 was in that posture. The amount of time the patient is active (e.g., standing) compared to inactivity (e.g., lying down) may affect the overall fluid distribution, may offset the recorded impedance measurements, and thus affect the target dry impedance and / or risk level described herein.

[0041] Some examples of IMD 10 provide the option of recording (e.g., logging) the occurrence of any cardiac events other than those consistent with an arrhythmia, such as QT interval / variation, repolarization changes, R-wave amplitude and morphology changes, etc. External device 12 may retrieve a log of such events from IMD 10 as part of the non-impedance data. In other examples, external device 12 may be configured to perform a specific function, such as a programmer for dialysis system 14 and / or IMD 10. Figure 4 As explained in detail in the description of , medical system 2 may involve a programmer to calibrate settings / parameters programmed in dialysis system 14 and / or IMD 10 based on impedance data received from IMD 10 (e.g., via patient computing devices 6A and / or 6B). In some examples, external device 12 may receive from computing device 6 some of the physiological data described herein sensed or collected by the computing device.

[0042] Similar to or as part of the memory query of IMD 10, external device 12 may receive impedance data and, in some cases, other physiological data. The processing circuit and / or dedicated logic circuit of external device 12 may utilize the received data to improve risk assessment in the preparation of dialysis treatment course. The telemetry hardware (e.g., communication circuit) of IMD 10 may return data in response to a request from external device 12. According to an exemplary technique, by utilizing the impedance data described herein to continuously monitor the fluid state of patient 4, external device 12 may implement control (e.g., physician control or automatic system control) of dialysis parameters (e.g., blood flow rate, fluid removal rate, ultrafiltration rate, duration and / or temperature) during dialysis treatment course, thereby effectively preventing the occurrence of possible or possible adverse events and negatively affecting the health of patient 4. External device 12 may calibrate one or more dialysis parameters in response to changes in blood volume (BV), dialysate conductivity, urea dynamics and / or thermal energy balance.

[0043] Under the control of at least one processor, the telemetry hardware of IMD 10 may receive downlink telemetry from and send uplink telemetry to external device 12 via an antenna, which may be internal and / or external. Providing physicians with insight into dialysis sessions at any time (e.g., on demand) presents many advantages, adds meaningful patient benefits to the early detection capabilities of clinical data for other health events (e.g., heart failure), and enables physicians (e.g., clinicians) to predict adverse effects of dialysis sessions on patient 4 and mitigate / prevent harm to the patient through multiple procedures.

[0044] As will be discussed below Figure 4Discussed in more detail, one or more remote computing devices of computing system 20 may interact with IMD 10 via a network in a manner similar to external device 12, e.g., to program IMD 10 and / or retrieve data from IMD 10. For example, a remote computing service (which may be similar to Medtronic The external device 12 may communicate with the IMD 10 directly via a network connection and / or indirectly via an external device 12 ) provided by the network.

[0045] The EHR 18 represents a collection of database systems maintained by government agencies and / or health care providers, and includes an electronic version of a patient's medical record maintained by a provider over time, and may include all key administrative clinical data related to a person under a particular provider's care, including demographics, progress notes, problems, medications, vital signs, past medical history, dialysis run history, recorded vital signs (e.g., weight, blood pressure), immunizations, laboratory data, and radiology reports. The EHR 18 may provide the external device 12 with automatic access to any information about the patient 4. In some examples, the external device 12 may use this information in the above-mentioned risk assessment for an upcoming dialysis session.

[0046] In other examples of medical system 2, processing circuitry in a wearable device (such as patient device 6B) may perform logic that is the same or similar to logic performed by processing circuitry of IMD 10 and / or other processing circuitry as described herein. In this manner, a wearable device or other device may perform some or all of the techniques described herein in the same manner as described herein with respect to IMD 10.

[0047] Figure 1B A method of treating a patient with a first medical device and a second medical device according to one or more examples of the present disclosure is illustrated. Figure 1A In some examples, the first medical device may be configured to measure the impedance of the interstitial space, and the second medical device may be configured to measure the impedance of the intravascular space.

[0048] In medical system 2, a first medical device (e.g., IMD 10A) and / or a second medical device (e.g., IMD 10B) may be configured to provide (e.g., periodic and / or continuous) impedance measurements (and in some cases measurements of other physiological parameters) to estimate fluid volume (e.g., blood volume, interstitial volume, and / or a combination of blood volume and interstitial volume) of patient 4. Such an estimate provides insight into determining the amount of fluid to be removed during an upcoming dialysis session. In this case, external device 12 may receive impedance measurements (e.g., impedance measurements recorded every hour or every twenty minutes), and by implementing the techniques described herein, these measurements are actually fluid volume measurements.

[0049] Using fluid volume measurements based on any one or more of the intravascular fluid space impedance measurements, the extravascular fluid space impedance measurements, and / or the interstitial fluid space impedance measurements, the external device 12 can generate information (e.g., instructions) that guides the dialysis procedure to remove excess fluid from the patient 4. Once removed, the body weight of the patient 4 (which can be referred to as the dry weight) corresponds to a specific impedance measurement (by IMD 10A and / or IMD 10B), and the impedance measurement can be referred to as dry impedance. Generally speaking, dry impedance is a target impedance (e.g., level) determined at the end of a dialysis course (e.g., when the patient 4 has reached his or her ideal hydration state). In one example, the external device 12 can be used to determine a net filtration rate based on impedance measurements for the interstitial space and impedance measurements for the intravascular space for the interdialytic period between a dialysis course and a previous dialysis course and / or the intradialytic period during a dialysis course.

[0050] Figure 1B An IMD 10A is depicted positioned in a substernal position to record impedance measurements of the extravascular space. These impedance measurements can be used as an indirect measurement of the volume of fluid in the intravascular space. In addition to or in lieu of the IMD 10A, various medical devices (such as Figure 1B An IMD 10B) may be positioned in the intravascular space to directly record impedance and may record intravascular and / or interstitial fluid space impedance measurements. An example of an IMD 10B may be an intracardiac pacemaker in the right ventricle of a heart for measuring impedance data and / or non-impedance data including heart sounds. The IMD 10A may also be configured to measure non-impedance data including ECG (R wave) morphology.

[0051] Figure 2 is an example of one or more techniques described herein. Figure 1A and Figure 1B A functional block diagram of an example configuration of an IMD 10.

[0052] In the illustrated example, IMD 10 includes electrodes 36A and 36B (collectively, “electrodes 36”), antenna 26, processing circuitry 50, sensing circuitry 52, communication circuitry 54, storage device 56, switching circuitry 58, and sensor 62. Although the illustrated example includes two electrodes 36, in some examples, an IMD that includes or is coupled to more than two electrodes 36 may implement the techniques of the present disclosure. Figure 2 Not illustrated in FIG. 3 , IMD 10 may include therapy delivery circuitry or other therapy delivery mechanisms to deliver therapy, such as pacing or other stimulation via electrodes 36 .

[0053] In one example, IMD 10 may record impedance measurements (and possibly other diagnostic factors) as part of recorded / uploaded patient data. IMD 10 may be positioned in one or more locations to allow electrodes 36 to sense impedance over a period of time, and then combine their respective impedance measurements into an estimate of fluid volume (e.g., plasma volume) for that period of time. As described herein, fluid volume may be used to control the performance of a medical procedure to remove excess or unwanted fluid (e.g., a dialysis session).

[0054] Processing circuitry 50 may include fixed function circuitry and / or programmable processing circuitry. Processing circuitry 50 may include any one or more of a microprocessor, a controller, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field programmable gate array (FPGA), or equivalent discrete or analog logic circuitry. In some examples, processing circuitry 50 may include multiple components (such as any combination of one or more microprocessors, one or more controllers, one or more DSPs, one or more ASICs, or one or more FPGAs) and other discrete or integrated logic circuitry. The functionality attributed to processing circuitry 50 herein may be embodied in software, firmware, hardware, or any combination thereof.

[0055] The sensing circuit 52 may be selectively coupled to the electrode 36 via the switch circuit 58, for example, to sense the electrical activity of the heart of the patient 4, for example, by selecting the electrode 36 for sensing the electrical activity of the heart and the polarity referred to as the sensing vector, as controlled by the processing circuit 50. The sensing circuit 52 may sense the signal from the electrode 36, for example, to generate cardiac EGM data or ECG data as an example of physiological parameter data. The sensing circuit 52 may monitor the signal from the sensor 62 to process various sensor measurements to include it as part of the physiological parameter data. The processing circuit 50 may control one or more sensors 62 to sense the patient data in some form. Examples of one or more sensors 62 for sensing physiological parameter data include any of the following: an accelerometer (e.g., a three-axis accelerometer) for sensing patient activity data, posture data, or heart sound data; a pressure sensor; an optical sensor; a gyroscope; a thermometer; a torque sensor, etc. Various metrics enable standardized measurements for each sample (e.g., a timestamp) of the sensed patient data and enable differentiation of multiple samples. In some examples, sensing circuit 52 may include one or more filters and amplifiers for filtering and amplifying signals received from electrodes 36 and / or sensor 62 .

[0056] Communication circuitry 54 may include any suitable hardware, firmware, software, or any combination thereof, for communicating with another device, such as external device 12, another networked computing device, or another IMD or sensor. Under the control of processing circuitry 50, communication circuitry 54 may receive downlink telemetry from external device 12 or another device and send uplink telemetry to it via an internal or external antenna, such as antenna 26. Among other things, processing circuitry 50 may communicate with external devices (e.g., external device 12) and devices such as Medtronic The antenna 26 and the communication circuit 54 can be configured to communicate via inductive coupling, electromagnetic coupling, near field communication (NFC), radio frequency (RF), WiFi or other proprietary or non-proprietary wireless communication scheme to transmit and / or receive signals.

[0057] In some examples, storage device 56 includes computer-readable instructions that, when executed by processing circuit 50, cause IMD 10 and processing circuit 50 to perform various functions attributed to IMD 10 and processing circuit 50 herein. Storage device 56 may include any volatile medium, non-volatile medium, magnetic medium, optical medium, or electrical medium, such as random access memory (RAM), read-only memory (ROM), non-volatile RAM (NVRAM), electrically erasable programmable ROM (EEPROM), flash memory, or any other digital medium. As an example, storage device 56 may store programmed values ​​of one or more settings and / or operating parameters of IMD 10 and / or data collected by IMD 10 for transmission to another device using communication circuit 54. The data stored by storage device 56 and transmitted by communication circuit 54 to one or more other devices may include patient data described herein for controlling dialysis treatment parameters and determining risk levels for dialysis treatments.

[0058] Sensing circuitry 52 may capture signals from any one or more of electrodes 36 and / or sensors 62 to, for example, generate physiological parameter data for processing by hardware / software (e.g., within IMD 10, external device 12, and / or another device) to facilitate (e.g., locally or remotely) monitoring of fluid volume and patient health (e.g., via an external computing system, such as a network-accessible device running a computing service). The hardware / software referenced above may include a software application configured with logic to generate additional patient data, such as data describing a risk level for an adverse outcome associated with a dialysis session.

[0059] Sensing circuit 52 converts the signal corresponding to the sensed electrical activity or other activity into a signal in digital form and provides the digitized signal to processing circuit 50 for logic analysis. Logic can guide processing circuit 50 to apply pattern recognition techniques to interpret the electrical activity vector recorded in the corresponding cardiac EGM data as one or more of the above components. In some examples, the waveform can indicate the initial detection of a cardiac event. Processing circuit 50 generates output data indicating a specific cardiac event type as a classification of the detected cardiac event for display.

[0060] The processing circuit 50 may execute logic (e.g., software code implementing an algorithm) to determine parameter values ​​for some functions (including patient health monitoring and health event detection functions), such as determining whether a patient is experiencing a health change (e.g., an increased likelihood of HF) based on one or more criteria. As described herein, this function may be enhanced by monitoring operations configured to warn or prevent adverse effects associated with dialysis.

[0061] Processing circuitry 50 and / or sensing circuitry 52 may read / write patient data from / to storage device 56. Processing circuitry 50 and / or sensing circuitry 52 may be configured to periodically or continuously record (e.g., monitor) physiological parameter data (e.g., impedance data). In some examples, processing circuitry 50 and / or sensing circuitry 52 may be configured to record impedance and other physiological parameter data at a first rate during interdialytic periods and at a second, higher rate during intradialytic periods. Processing circuitry 50 and / or sensing circuitry 54 may communicate with each other via a communication channel (e.g., Connect) to upload patient data to a computing device such as Figure 1A Patient device 6A, Figure 1A External device 12 or Figure 1A The impedance data (and in some cases, other physiological data) may be presented substantially continuously or in substantially real time during the intradialytic period, as recorded at a higher rate or resolution.

[0062] Figure 3 1 is a block diagram illustrating an example configuration of components of the external device 12. Figure 3 In the example of FIG. 8 , the external device 12 includes a processing circuit 80 , a communication circuit 82 , a storage device 84 , and a user interface 86 .

[0063] The processing circuit 80 may include one or more processors configured to implement functions and / or processing instructions for execution within the external device 12. For example, the processing circuit 80 may be capable of processing instructions stored in the storage device 84. The processing circuit 80 may include, for example, a microprocessor, a DSP, an ASIC, an FPGA, or an equivalent discrete or integrated logic circuit or a combination of any of the foregoing devices or circuits. Thus, the processing circuit 80 may include any suitable structure, whether hardware, software, firmware, or any combination thereof, to perform the functions attributed to the processing circuit 80 herein.

[0064] The communication circuitry 82 may include any suitable hardware, firmware, software, or any combination thereof, for communicating with another device, such as the IMD 10. Under the control of the processing circuitry 80, the communication circuitry 82 may receive downlink telemetry from the IMD 10 or another device, and send uplink telemetry to the IMD or another device. The communication circuitry 82 may be configured to transmit and / or receive signals via inductive coupling, electromagnetic coupling, NFC, RF communication, Bluetooth, WiFi, or other proprietary or non-proprietary wireless communication schemes. The communication circuitry 82 may also be configured to communicate with a device other than the IMD 10 via any of various forms of wired and / or wireless communications and / or network protocols.

[0065] Storage device 84 may be configured to store information within external device 12 during operation. Storage device 84 may include a computer-readable storage medium or a computer-readable storage device. In some examples, storage device 84 includes one or more of short-term memory or long-term memory. Storage device 84 may include, for example, RAM, DRAM, SRAM, a magnetic disk, an optical disk, flash memory, or various forms of EPROM or EEPROM. In some examples, storage device 84 is used to store data indicating instructions for execution by processing circuit 80. Storage device 84 may be used by software or applications running on external device 12 to temporarily store information during program execution.

[0066] In some examples, external device 12 and IMD 10 may be Low Energy (BLE) or Bluetooth enabled devices, and are therefore capable of transmitting data to each other, such as sensor data including impedance measurements via a radio access technology (RAT). It should be noted that these devices can utilize any type of wireless or even network connection to accomplish the transmission of sensor data. The IMD 10 can run software code (e.g., software code for one or more communication protocols) to depict the sensor data in a message as packet data for transmission (e.g., via a wireless connection).

[0067] Processing circuitry 80 may transmit instructions to IMD 10 requesting IMD 10 to export the collected data (e.g., cardiac event data and / or sensor data) to external device 12 (e.g., memory query). In turn, external device 12 may receive the data collected from IMD 10 and store the collected data in storage device 84. The data received by external device 12 from IMD 10 may include impedance data and other patient data described herein.

[0068] The data exchanged between the external device 12 and the dialysis system 14 may include device settings and / or operating parameters as well as the physiological data described herein. The external device 12 may transmit data including computer-readable instructions that, when implemented by the dialysis system 14, may control the dialysis system to set one or more initial settings / parameters and / or change one or more settings / parameters. The processing circuit 80 may transmit instructions to update any one or more of the dialysis parameters described herein (e.g., duration, frequency, amount of fluid to be removed, etc.) based on the impedance data and / or other physiological parameters (e.g., dry impedance estimation) and / or risk level.

[0069] Processing circuitry 80 may execute logic (e.g., software code implementing an algorithm) to determine parameter values ​​for controlling the performance of a dialysis treatment session by dialysis system 14. As described herein, the logic may be configured to advantageously use impedance data collected by IMD 10. In addition, processing circuitry 80 may also execute logic to determine parameter values ​​for other functions, including patient health monitoring and health event detection functions, to determine, for example, whether a patient is experiencing a change in health based on one or more criteria. As described herein, this functionality may be enhanced by monitoring operations that are configured to enhance control of dialysis and prevent adverse effects associated with dialysis.

[0070] A user, such as a clinician or patient 4, may interact with the external device 12 via the user interface 86. The user interface 86 includes a display (not shown), such as a liquid crystal display (LCD) or light emitting diode (LED) display or other type of screen, with which the processing circuit 80 may present information related to the patient 4, the dialysis patient, and the electrical activity in or around the heart (e.g., cardiac signals), for example, a risk level corresponding to the likelihood of adverse effects occurring if the patient 4 continues with the pending / scheduled dialysis treatment. In another example, the processing circuit 80 may present information indicating new parameter values ​​to update the dialysis system 14. Implementing the updated parameters improves the dialysis course by causing the dialysis system to change the performance of the dialysis course so that the dialysis course is no longer unsafe for the patient. For example, the processing circuit 80 may update parameters such as the frequency and / or duration of dialysis (e.g., to increase / decrease the number of dialysis courses per week, increase / decrease the amount of fluid to be removed, and / or increase / decrease the ultrafiltration rate during the dialysis course).

[0071] Among other things, the user interface 86 may include an input mechanism configured to receive input from a user, who may be a physician of the patient 4. The input mechanism may include, for example, any one or more of a button, a keypad (e.g., an alphanumeric keypad), a peripheral pointing device, a touch screen, or another input mechanism that allows a user to navigate through a user interface presented by the processing circuit 80 of the external device 12 and provide input. In other examples, the user interface 86 also includes audio circuitry for providing auditory notifications, instructions, or other sounds to the user, receiving voice commands from the user, or both.

[0072] The adverse effects mentioned above may result from how the dialysis session is performed by the physician and / or the dialysis system 14. Conventional dialysis therapy (including intradialytic ultrafiltration management) relies on estimates of dry weight, which often leads to adverse events, which often result in adverse events such as cramps, hypotension, and arrhythmias. The present disclosure describes techniques intended to enable continuous dialysis therapy monitoring and / or calibration in an open-loop or closed-loop manner to remove excess fluid as part of an innovative dialysis therapy.

[0073] The disclosed techniques may use impedance as a surrogate for fluid volume and thus indicate the amount of fluid to be removed in the upcoming / next dialysis session. Continuous impedance measurements may be used in intradialytic ultrafiltration management to initialize certain parameters for controlling the next dialysis session, and then (continuously or as needed) update these (e.g., ultrafiltration) parameters for subsequent sessions, thereby reducing the likelihood of any adverse events. In addition, the processing circuit 80 may be configured to use other diagnostic measurements corresponding to the interdialytic period (heart rate, arrhythmias, PVCs, QT changes, repolarization changes, potassium estimates, R wave amplitude and morphology changes, etc.) to set initial parameters or customize these parameters for the next dialysis session.

[0074] Figure 4 is a block diagram illustrating an example system including multiple computing devices for dynamic dialysis calibration as described herein. Measurement device 90 represents any conceivable mechanism for sensing impedance and / or recording impedance measurements, and may be an example of, combined with, or used as a replacement for an IMD 10 for providing impedance measurements to other computing devices. Measurement device 90 may be configured to record impedance measurements and / or other physiological parameters. In addition to patient device 6, Figure 4 Any other computing device depicted in the may be configured to receive / send impedance measurements, including server 94 and remote computing devices 99A to 99N (collectively, "computing devices 99"). Figure 4 In the example of , the patient device 6 , the server 94 , and the computing device 99 are interconnected and can communicate with each other via the network 92 .

[0075] In by Figure 4 In the illustrated example, server 94 includes, for example, a storage device 96 for storing data retrieved from IMD 10 and processing circuitry 98. In one example, server 94 may be Figure 1A An example or portion of a computing system 20, and one or more computing devices 99 may be Figure 1A Alternatively, server 94 may operate in a manner similar to external device 12, such as when patient 4 is at home after receiving a previous dialysis session (e.g., an interdialysis session). Figure 494, but the computing device 99 may similarly include a storage device and a processing circuit. The processing circuit 98 may include one or more processors configured to implement functions and / or process instructions for execution within the server 94. For example, the processing circuit 98 may be capable of processing instructions stored in the storage device 96. The processing circuit 98 may include, for example, a microprocessor, a DSP, an ASIC, an FPGA, or an equivalent discrete or integrated logic circuit or a combination of any of the aforementioned devices or circuits. Therefore, the processing circuit 98 may include any suitable structure, whether hardware, software, firmware, or any combination thereof, to perform the functions attributed to the processing circuit 98 herein. The processing circuit 98 of the server 94 and / or the processing circuit of the computing device 99 may implement any of the techniques described herein to analyze information received from the IMD 10, for example, to determine whether the patient's health state has changed, to determine whether the prediction criteria are met and / or the error prediction criteria are met.

[0076] In some cases, server 94 may be configured to provide a secure storage site for data that has been collected from IMD 10, patient device 6, and / or external device 12. In some cases, server 94 may compile the data in a web page or other document via computing device 99 for viewing by trained professionals such as physicians and clinicians. Figure 4 One or more aspects of the illustrated systems may be used with a device manufactured by Medtronic It is implemented by the general network technologies and functions similar to those provided by Network.

[0077] Storage device 96 may include a computer-readable storage medium or a computer-readable storage device. In some examples, storage device 96 includes one or more of short-term memory or long-term memory. Storage device 96 may include, for example, RAM, DRAM, SRAM, a magnetic disk, an optical disk, flash memory, or various forms of EPROM or EEPROM. In some examples, storage device 96 is used to store data indicating instructions for execution by processing circuit 98.

[0078] As part of the remote monitoring operation of patient 4, server 94 may transmit instructions for medical intervention to one or more computing devices 99 located at the patient's 4 physician or patient's 4 caregiver. For example, such instructions for medical intervention may include instructions to change medication dosage, timing, or selection, instructions to schedule a clinician visit, or instructions to seek medical attention. In another example, server 94 may generate an alert to transmit to patient device 6 for presentation to patient 4. In another example, the alert may be based on the state of patient 4's medical condition, which may enable patient 4 to proactively seek medical attention before receiving instructions for medical intervention. In this way, patient 4 may take autonomous action to address his or her medical condition as needed, which may help improve clinical outcomes for patient 4.

[0079] In some examples, one or more of computing devices 99 may be a tablet or other smart device located with a clinician through which the clinician may program, receive alerts from, and / or interrogate IMD 10. For example, such as when patient 4 is between clinician visits, the clinician may access various patient data, including instrument measurements, sensor data, physiological parameters of IMD 10, electrocardiograms, and / or indications of patient health collected by IMD 10 through computing device 99 to check the status of a medical condition.

[0080] Figure 5 is a flow chart of example operations for impedance-based dialysis control and / or calibration according to one or more examples of the present disclosure. In some examples, the example operations may be performed by a physician's computing device (such as Figure 1A to Figure 1B external device 12) practice, in which the patient is dialyzed via a dialysis system (such as Figure 1A dialysis system 14) to receive dialysis.

[0081] Access to medical devices such as Figure 1A The calculation device of the impedance measurement result of the IMD 10) can be used to calculate the accurate fluid volume estimate of the patient's body before and / or after (e.g., immediately) the dialysis treatment session and (if necessary) calibrate the dialysis system (such as Figure 1A dialysis system 14) to perform treatment and safety procedures during the dialysis session and / or the next dialysis session to facilitate treatment of the patient (such as Figure 1A to Figure 1B 4); at least for this reason, the example operations are described below with reference to these elements. It will be appreciated that, assuming (e.g., relevant) impedance data is available, the physician device can determine the fluid volume estimate at any time (including different times of the day / week). More importantly, the physician device can determine the fluid volume estimate based on impedance data collected by and retrieved from the patient's medical device.

[0082] exist Figure 5 In an example operation of , processing circuitry of external device 12 determines a dry impedance (100) based on impedance data of a patient 4 undergoing a dialysis session and one or more medical devices including IMD 10. Processing circuitry of external device 12 may output the dry impedance for presentation to a physician and / or configuration of dialysis system 14, for example, by establishing the dry impedance as a target (e.g., standard) for a dialysis session (110). To illustrate with an example dialysis session, when patient 4 arrives at a medical facility to receive their dialysis treatment, processing circuitry of external device 12 may determine one or more fluid volume estimation parameters for the patient based on various impedance data. Impedance data relied upon to determine the current amount of fluid in the patient may include impedance measurements collected / recorded during an intradialytic period, which covers any time during the current dialysis session, and / or during an interdialytic period, which covers any time between a previous (e.g., preceding) dialysis session and the current dialysis session. The patient may have their own personalized / customized dry impedance for that session and vary based on day of week, arrhythmia or heart rate, amount of fluid estimated based on impedance changes during interdialytic sessions, etc. The physician may receive dry impedance for one or more subsequent dialysis sessions.

[0083] The IMD 10 may record impedance data for the determination mentioned above at any time point before the current dialysis course and / or after the previous dialysis course. Dry impedance may be a measurement result (e.g., a value (in ohms)) determined based on impedance data collected during and / or after the previous dialysis course. The processing circuit of the external device 12 may implement a mechanism (e.g., a mathematical model such as a machine learning model) to predict an accurate (body) fluid volume estimate corresponding to one or more (e.g., historical and / or simultaneous) impedance measurements. An example model may define a function for the current dialysis course of patient 4 that generates the dry impedance of patient 4 as an output based on multiple model parameters (e.g., impedance-based features). The function may be configured to accept as input some model parameters, including impedance measurements indicating the amount of fluid removed in the previous dialysis course, the amount of fluid remaining after the previous dialysis course, the (most recent) dry impedance, a current fluid volume estimate including the amount of fluid before the dialysis course, etc. The most recent dry impedance may be a dry impedance measurement recorded immediately after the end of the previous dialysis course. In one example, dry impedance may represent the (eg, target) dry weight of the patient 4. In some examples, the above-mentioned models are combined with one or more additional / alternative parameters, including but not limited to day of the week, heart rate measurements, Figure 1A EHR 18 patient history, etc.

[0084] like Figure 5As illustrated in , the processing circuitry of the external device 12 compares the dry impedance to the wet impedance based on impedance data collected before the dialysis session and / or after the previous dialysis session (120). The comparison can produce a new / updated dry impedance (e.g., a target). Because the impedance measurements provide accurate fluid volume measurements, the processing circuitry of the external device 12 can determine the amount of fluid in the patient 4 after some (if not a large amount) of the fluid has been removed through the dialysis treatment. In combination with the current body weight, the determined amount of fluid can be used to determine the dry weight of the patient 4. Therefore, the external device 12 can use the dry impedance as a personalized dry impedance (e.g., a target threshold or standard) for initializing certain dialysis parameters for the next dialysis session. In some examples, the processing circuitry of the external device 12 can store a new / updated dry impedance calculated based on the impedance measurements recorded after the current dialysis session is successfully completed.

[0085] Similarly, the processing circuitry of the external device 12 may have determined the dry impedance after a dialysis session was completed; since the previous dry impedance is available / known, the processing circuitry of the external device 12 may establish that impedance value as a target for the current dialysis session and / or the next dialysis session. If the dry impedance from the previous session is not available / unknown, the wet impedance may be used to estimate the dry impedance for the current dialysis session. Alternatively, the dry impedance may be set to a default value for at least the initial dialysis session. Thus, the external device 12 may utilize the dry impedance of the previous dialysis session as a personalized dry impedance (e.g., a target threshold or standard) for initializing certain parameters of the current dialysis session.

[0086] The physician may prescribe a calibration period for the patient 4 at the beginning of the current dialysis session. For the patient 4 who is about to undergo a dialysis session, the processing circuitry of the external device 12 may also personalize the dry impedance estimate during the calibration period based on various additional factors such as implant location, tissue type surrounding the implant (for ICM), seasonal weather (humidity and sweating), etc.

[0087] During the calibration period, a risk assessment may be performed for adverse events. An example mechanism (e.g., a machine learning model) for performing risk assessment may be based on multiple factors (e.g., model parameters) that may fluctuate from the beginning of a dialysis course to the end of the course, and is configured to generate a risk level (e.g., quality) as an output that indicates the probability (e.g., likelihood) of an adverse effect occurring in a patient 4 receiving a dialysis course. The machine learning model may accept as input a combination of patient physiological parameters, including, but not limited to, time-stamped measurements for heart rate (HR), heart rate variability (HRV), blood pressure, fluid volume in the patient 4, and the like. Another set of parameters may be combined with data from the patient 4's medical history, including adverse medical history, such as a history of arrhythmias, a history of HF, and the like. At the beginning of a dialysis course, the processing circuitry of the external device 12 may calculate another risk level (e.g., a risk level for a particular adverse event occurring due to (e.g., from) treatment of the (current) dialysis course). This risk level / probability can be more granular / acute and / or based on additional patient physiological parameters, such as the amount of fluid from impedance data (e.g., fluid volume), incidence of arrhythmias since previous dialysis sessions, current blood pressure, levels of various electrolytes, heart rate, respiratory rate, temperature, current hydration level, and / or other physiological parameters.

[0088] During a dialysis course, the processing circuitry of the external device 12 may calculate an example acute risk level based on changes in impedance measurements, changes in heart rate, changes in respiration rate, changes in temperature, changes in hydration, and the like. The acute risk level may be used to calibrate one or more dialysis parameters, including when to stop dialysis treatment (i.e., duration). The risk level may prompt calibration of parameters for future (e.g., next) dialysis courses for the patient. The acute risk level may reflect a short-term risk assessment of the duration of the dialysis course. For this course and / or the next dialysis course, the external device 12 may determine the probability of one or more specific adverse effects occurring in the patient 4. Examples of these adverse effects include decreased hydration, abnormal blood pressure (e.g., hypertension or hypotension), and the like. Additional sensor data (e.g., blood pressure measurements for the day and other short-term physiological data) may enhance the accuracy of the acute risk level / short-term risk assessment.

[0089] according to Figure 5, the processing circuitry of external device 12 determines whether to calibrate the dialysis session (130). Based on the determination not to adjust the treatment for the dialysis session ("No" of 130), the processing circuitry may continue to apply the current dialysis treatment originally planned for patient 4 (140). Multiple parameters may define the treatment, such that if the processing circuitry of external device 12 determines that the wet impedance of patient 4 meets the dry impedance target, the processing circuitry of external device 12 refrains from substantially changing any one or more dialysis parameters used to control the performance of the next (now current) dialysis session. The same parameters used for the previous session should provide the same or similar results.

[0090] Based on the determination to adjust the treatment for the next dialysis session (“YES” of 130), the processing circuitry may update one or more dialysis parameters, such as dialysis duration, frequency, and / or ultrafiltration rate (150). Once the current dialysis session begins, the processing circuitry of the external device 12 detects one or more impedance changes in the recorded electrical activity; for example, by continuously monitoring the electrical activity in the patient 4, the processing circuitry of the external device 12 may determine an accurate estimate of how much fluid has been removed from the patient 4 and / or a track of impedance changes to determine whether to calibrate the ultrafiltration rate, duration, and / or estimated dry impedance.

[0091] Figure 6 is a flow chart illustrating example operations for monitoring a patient undergoing dialysis according to one or more examples of the present disclosure. In some examples, the example operations may be directed to a computing device (such as a computer) for a patient's dialysis treatment. Figure 1A to Figure 1B The patient device 6 and / or external device 12 can be accessed from the patient's medical device (such as Figure 1A A device that calculates impedance measurements of an IMD 10) can provide many benefits to patients and their health; at least for this reason, example operations are described below with reference to these elements.

[0092] according to Figure 6 In the illustrated example, processing circuitry of medical system 2 initiates a risk assessment based on one or more diagnostic factors (including impedance measurements) and determines a fluid volume (e.g., of blood) (200). In general, the patient may benefit from better medical care, but at least from an accurate risk assessment. The risk assessment may prevent adverse effects during a dialysis session, but remote patient monitoring may also be performed on an ongoing basis (if necessary) to further prevent patient harm (e.g., from hypertension). As described herein, the risk assessment is performed as part of a dialysis session (i.e., intradialytic) or in preparation for a dialysis session (e.g., between dialysis sessions) that is performed by Figure 1A The dialysis system 14 represents equipment that performs a medical procedure for removing fluid from the human body.

[0093] exist Figure 6In an example operation of , the processing circuit determines whether an acceptable risk level exists for the patient based on one or more diagnoses (210). The risk level is derived from the risk assessment described above and indicates the probability (e.g., likelihood) of one or more adverse effects occurring given the impedance measurement results. The one or more adverse effects may refer to general adverse effects or specific effects (e.g., heart failure). There are many factors that may be used to make this determination. Based on a determination that the risk level is acceptable ("yes" of 210), the processing circuit may allow the next dialysis course to proceed (260). The next dialysis course may be performed immediately after the risk assessment (e.g., an intra-dialysis period) or may be scheduled for a later date (e.g., an inter-dialysis period). There may be a calibration period while the next dialysis course is pending to ensure that the dialysis system is properly configured based on the patient's impedance data.

[0094] Based on a determination that the risk level is unacceptable (“NO” of 210), the processing circuitry may output one or more adverse effects via a display device and determine an amount of fluid to be removed at the next dialysis session (220). The processing circuitry may continue to determine satisfaction of specific criteria (230), and based on a determination that specific criteria are not satisfied (“NO” of 230), the processing circuitry may end or terminate the next dialysis session because the dialysis session is unsafe and may be harmful to the patient (270). Thus, the criteria may be configured to determine whether it is in the best medical interest of the patient to receive the next dialysis session. For patients requiring dialysis, the processing circuitry may allow the next dialysis session to proceed, in which case the processing circuitry may change one or more dialysis parameters to reduce the patient's risk level, such as ultrafiltration rate or dialysis duration.

[0095] Based on determining that a particular criterion is met ("yes" of 230), the processing circuit may perform a next action depending on whether the current time falls within the intra-dialysis period or the inter-dialysis period. In some examples, the processing circuit 80 of the external device 12 operated by a physician initiates a risk assessment prior to a dialysis session. When communicatively coupled to the dialysis system 14, the processing circuit 80 may determine that a physician initiated a risk assessment (e.g., in a hospital) (intra-dialysis of 230), and for at least that reason, continue to update the dialysis session settings / parameters to adjust the execution of the next dialysis session (240). In some examples, the physician may initiate an update of the dialysis session settings / parameters based on the risk level. In other examples, the dialysis system 14 performs an automatic risk assessment, in which case updating the dialysis session settings / parameters may be automatic based on the risk level.

[0096] In other examples, the processing circuitry 50 of the IMD 10 (and / or the processing circuitry of the patient device 6) may, for example, cooperate with one or more remote computing devices of the computing system 20 to coordinate patient monitoring operations. When communicatively coupled to each other, these devices may monitor patient data and generate a warning if the patient data indicates a significant decline in patient health (e.g., a condition such as arrhythmia may occur). To illustrate by way of example, when the impedance measurements are continuously monitored and communicatively coupled to the patient device 6, the processing circuitry 50 of the IMD 10 may determine at some point that the impedance measurements indicate that the patient is in poor health, such as hypertension (dialysis room of 230), and for at least that reason, transmit a warning for display to the patient via the patient device 6 or to the physician via the external device 12 and / or the dialysis system 14 (250).

[0097] In examples where the IMD 10 is equipped with appropriate therapy delivery circuitry, the IMD 10 may continue to provide some therapy, if appropriate. An example therapy that the IMD 10 may deliver includes delivering a cardioversion or defibrillation shock with the aid of an output circuit that determines whether to deliver a monophasic or biphasic pulse, whether the housing electrode is used as a cathode or an anode, and which electrodes are involved in the delivery of the cardioversion or defibrillation pulse. Such functionality may be provided by one or more switches or switching circuits of the therapy delivery circuitry.

[0098] Figures 5 and 6 The illustrated order and flow of operations are examples. In other examples according to the present disclosure, more or fewer thresholds may be considered. Further, in some examples, as directed by the user, the processing circuit may or may not perform the operation, for example, via the external device 12 or the computing device 99. Figure 5 or Figure 6 For example, a patient, clinician, or other user can turn on or off functionality for identifying changes in a patient's health status (e.g., using Wi-Fi or cellular service) or locally (e.g., using an application provided on the patient's cell phone or using a medical device programmer).

[0099] Figure 7 300 is a graph illustrating dynamic dialysis calibration according to the techniques described herein. Graph 300 may depict a series (e.g., continuous) of impedance measurements 302 recorded by a medical device over multiple days. The amount of time tracked by graph 300 may be divided into intra-dialytic time periods 304 (e.g., time periods in which a dialysis session is occurring or is about to occur) and inter-dialytic time periods 306 (e.g., time periods between dialysis sessions in which no dialysis session is occurring or is about to occur), for ease of illustration, Figure 7 Only some of these periods are marked.

[0100] The physician may use a computing device (e.g., Figure 1A The computing device may program the medical device to record impedance measurements according to a schedule. In this manner, the medical device may record measurements of the graph 300 at any resolution. In one example, the computing device generates the graph 300 with an example resolution that is set to record impedance measurements of the medical device every hour during the interdialytic period and / or every 5 minutes during the intradialytic period. The computing device may display the graph 300 to help the physician manage the patient's dialysis treatment.

[0101] As depicted in graph 300, an estimated (target) dry impedance 308 may be determined as a more accurate surrogate for fluid volume based on the impedance data. One example use of impedance data may be to determine the estimated dry impedance 302 as representing a duration or time limit indicating when to end a dialysis session. In this way, the estimated dry impedance 302 may be used as a personalized or calibrated target impedance value / level for a patient. The estimated dry impedance at any point in time may be based on an estimate of fluid accumulation from previous impedance measurements, and may be based on other factors including the day of the week and other diagnostic information. The computing device may continue to update the estimated dry impedance 308 while the medical device continuously records impedance measurements at an example resolution for the remainder of the intra-dialysis session. These continuous measurements may be used to estimate body fluid composition or hydration status to determine when to end a dialysis session or to change dialysis parameters as a closed-loop control mechanism.

[0102] After a dialysis session and / or in preparation for the next dialysis session (e.g., during an interdialytic period), the medical device may continue to record impedance measurements at the above example resolution or another resolution. These measurements may be used to calculate a wet impedance value 310 and dialysis parameters for the next dialysis session. An example dialysis parameter may be an ultrafiltration rate and / or duration calculated based on the wet impedance and target dry impedance values, day of the week, and / or other diagnostic factors.

[0103] To generate chart 300, the medical device may sense the impedance of a fluid (e.g., plasma) and record impedance measurements at various time points during a day. One or more impedance measurements may indicate the volume of the fluid (e.g., plasma) at one or more corresponding time points. Thus, a computing device performing dynamic dialysis calibration may utilize one or more recorded impedance measurements as a substitute for the volume of the fluid (e.g., plasma). The medical device may record corresponding impedance measurements from any one or more spaces (e.g., body cavities) in a plurality of spaces (e.g., body cavities) (such as in an intravascular space and / or an extravascular or interstitial space). In some examples, the medical device may include an IPG, a leadless pacemaker device, an implantable cardioverter-defibrillator (ICD), or a CRT device, wherein electrodes of intravascular leads measure impedance (e.g., in ohms) while capturing electrical activity (e.g., signals) at one or more locations (e.g., within the intravascular space). Thus, each lead in the intravascular space may be configured to sense electrical activity from a different location on the heart. In other examples, the medical device may include an insertable cardiac monitor (ICM), an extravascular (EV) implantable cardioverter-defibrillator (ICD), a subcutaneous ICD, and / or a skin patch, wherein electrodes of an extravascular lead measure impedance while capturing electrical activity (e.g., signals) in one or more locations within the extravascular space (e.g., in the substernal space). In one example, the ICM may be combined with the ICD into a single medical device, wherein the patient benefits from extravascular impedance monitoring and pacing therapy (such as anti-tachycardia pacing). In another example, the medical device may be configured to record impedance measurements from a combination of the interstitial space (within the extravascular space) and the intravascular space in a volume measurement vector. Thus, multiple devices (including non-medical devices) may be used to provide impedance measurements and (possibly) orthogonal information about fluids in different fluid compartments in the body. As an alternative to the above example medical devices, a galvanometer (e.g., an EKG machine) may be configured to record impedance measurements.

[0104] In some examples, dynamic dialysis calibration is integrated into remote patient monitoring operations by computing system 20. If current patient activity indicates a high likelihood of adverse effects from the next dialysis session, the medical device may transmit a warning to computing system 20. Computing system 20 then performs a number of monitoring operations to at least notify the patient and / or their physician of unhealthy patient activity. To illustrate by way of example, the estimated stem impedance mentioned above may be incorporated into a heart failure (HF) detection algorithm, such as by replacing or supplementing the impedance score used in calculating a HF risk score. For example, Figure 1A The IMD 10 and / or external device 12 may use an estimated (target) truncal impedance instead of the HF detection algorithm (eg, TRIAGEHF available from Medtronic) TMalgorithm) is used, thereby operating as a patient-specific impedance threshold.

[0105] Figure 8 4 is a conceptual diagram illustrating an example machine learning model 400 configured to determine one or more of a dialysis parameter, a target dry weight, a fluid volume, or a risk of a dialysis session based on impedance measurements and, in some cases, other physiological parameter values. Machine learning model 400 is an example of a deep learning model or deep learning algorithm. One or more of IMD 10, computing device 6, external device 12, or computing system 20 may train, store, and / or utilize machine learning model 300, but in other examples, other devices may apply inputs associated with a particular patient to machine learning model 400. Some non-limiting examples of machine learning techniques include Bayesian probability models, support vector machines, K-nearest neighbor algorithms, and multilayer perceptrons.

[0106] like Figure 8 As shown in the example of , the machine learning model 400 may include three layers. The three layers include an input layer 402, a hidden layer 404, and an output layer 406. The output layer 406 includes the output of the transfer function 405 from the output layer 406. The input layer 402 represents each of the input values ​​X1 to X4 provided to the machine learning model 400. The number of inputs may be less than or greater than 4, including much greater than 4, such as hundreds or thousands. In some examples, the input value may be any of the values ​​described above. In some examples, the input value may include parameter values ​​described herein, such as impedance measurements, morphology or other parameters of ECG or heart sounds, heart rate variability, and arrhythmia metrics.

[0107] Each of the input values ​​of each node in the input layer 402 is provided to each node in the hidden layer 404. Figure 8 In the example of , hidden layer 404 includes two layers, one layer having four nodes and the other layer having three nodes, but fewer or greater numbers of nodes may be used in other examples. Each input from input layer 402 is multiplied by a weight and then summed at each node of hidden layer 404. During training of machine learning model 400, the weight of each input is adjusted to establish a relationship between the inputs to determine a score indicating whether a set of inputs may represent a particular risk level or health state for which certain dialysis parameters may be recommended. In some examples, one hidden layer may be incorporated into machine learning model 400, or three or more hidden layers may be incorporated into machine learning model 400, with each layer including the same or different numbers of nodes.

[0108] The results of each node within the hidden layer 404 are applied to a transfer function of the output layer 406. The transfer function can be linear or nonlinear, depending on the number of layers within the machine learning model 400. Example nonlinear transfer functions can be a sigmoid function or a rectifier function. The output 407 of the transfer function can be a score indicating the risk level (e.g., likelihood or probability) of an adverse health event due to a dialysis course. By applying patient parameter data to a machine learning model such as the machine learning model 400, the processing circuitry of the system 2 is able to determine the risks and / or parameters of dialysis with high accuracy, specificity, and sensitivity. This can facilitate improved treatment efficacy and safety, and improved patient health.

[0109] Fig. 9 504. The machine learning model 400 may be implemented using any number of models for supervised and / or reinforcement learning, such as, but not limited to, an artificial neural network, a decision tree, a naive Bayesian network, a support vector machine, or a k-nearest neighbor model, to name a few examples. In some examples, processing circuitry of one or more of IMD 10, computing device 6, external device 12, and / or computing system 20 initially trains the machine learning model 400 based on a training set data 500 that includes numerous instances of input data corresponding to various risk levels and / or other patient conditions. The output of the machine learning model 400 may be compared 504 to a target output 503 determined, for example, based on a label. Based on an error signal representing the comparison, processing circuitry implementing a learning / training function 505 may send or apply modifications to the weights of the machine learning model 400, or otherwise modify / update the machine learning model 400. For example, one or more of IMD 10, computing device 6, external device 12, and / or computing system 20 may modify machine learning model 400 to change a score generated by machine learning model 400 for each training instance in training set 500 in response to data applied to machine learning model 400.

[0110] Fig. 10A is a perspective view of an exemplary IMD 910A, which may be an ICM of FIGS. 1 to 2. Figure 3 An example configuration of an IMD 10 (e.g., IMD 10A) is provided. Fig. 10A In the example shown, IMD 910A can be embodied as a monitoring device having a housing 912, proximal electrodes 36A, and distal electrodes 36B. Housing 912 can also include a first major surface 914, a second major surface 918, a proximal end 920, and a distal end 922. Housing 912 encloses the electronic circuitry located within IMD 910A and protects the circuitry contained therein from body fluids. Housing 912 can be hermetically sealed and configured for subcutaneous implantation. Electrical feedthroughs provide electrical connections for electrodes 36A and 36B.

[0111] exist Fig. 10A In the example shown, IMD 910A is defined by a length L, a width W, and a thickness or depth D, and is in the form of an elongated rectangular prism, where the length L is much greater than the width W, which in turn is greater than the depth D. In one example, the geometry of IMD 910A—particularly the width W being greater than the depth D—is selected to allow IMD 910A to be inserted under the patient's skin using minimally invasive surgery and maintained in a desired orientation during insertion. For example, Fig. 10A The device shown includes radial asymmetry (particularly rectangular shape) along the longitudinal axis, which keeps the device in the correct orientation after insertion. For example, the spacing between the proximal electrode 36A and the distal electrode 36B can be in the range of 5 millimeters (mm) to 55mm, 30mm to 55mm, 35mm to 55mm, and 40mm to 55mm, and can be any range or single spacing of 5mm to 60mm. In addition, the length L of the IMD 910A can be in the range of 30mm to about 70mm. In other examples, the length L can be in the range of 5mm to 60mm, 40mm to 60mm, 45mm to 60mm, and can be any length or length range between about 30mm and about 70mm. In addition, the width W of the main surface 914 can be in the range of 3mm to 15mm, 3mm to 10mm, or 5mm to 15mm, and can be any single width or width range between 3mm to 15mm. The thickness of the depth D of the IMD 910A can be in the range of 2 mm to 15 mm, 2 mm to 9 mm, 2 mm to 5 mm, 5 mm to 15 mm, and can be any single depth or depth range of 2 mm to 15 mm. In addition, the IMD 910A according to the examples of the present disclosure has a geometry and size designed for ease of implantation and patient comfort. The examples of the IMD 910A described in the present disclosure can have a volume of 3 cubic centimeters (cm) or less, a volume of 1.5 cubic centimeters or less, or any volume between 3 cubic centimeters and 1.5 cubic centimeters.

[0112] exist Fig. 10A In the example shown, once inserted into the patient, the first major surface 914 faces outward, toward the patient's skin, and the second major surface 918 is located opposite the first major surface 914. Fig. 10A In the example shown, the proximal end 920 and the distal end 922 are rounded to reduce discomfort and irritation to surrounding tissue once inserted under the patient's skin. IMD 910A, including instruments and methods for inserting IMD 910A, is described, for example, in U.S. Patent Publication No. 2014 / 0276928, the entire contents of which are incorporated herein by reference.

[0113] The proximal electrode 36A is located at or near the proximal end 920, and the distal electrode 36B is located at or near the distal end 922. The proximal electrode 36A and the distal electrode 36B are used to sense cardiac EGM signals (e.g., ECG signals) and measure thoracic interstitial impedance outside the thorax, which EGM signals and thoracic interstitial impedance can be submuscular or subcutaneous. The EGM signals and impedance measurements can be stored in a memory of the IMD 910A, and the data can be transmitted via the integrated antenna 26A to another device, which can be another implanted device or an external device, such as the computing device 6 and the external device 12. In some examples, the electrodes 36A and 36B can be used additionally or alternatively to sense any biopotential signal of interest from any implant location, which can be, for example, an EGM, EEG, EMG, or neural signal. The housing 912 can accommodate Figure 2 The circuit of the IMD 10 is illustrated in .

[0114] In the example shown in FIG. 910A , the proximal electrode 36A is located at or proximate to the proximal end 920, and the distal electrode 36B is located at or proximate to the distal end 922. In this example, the distal electrode 36B is not limited to a flat, outwardly facing surface, but may extend from the first major surface 914 around the rounded edge 924 and / or the end surface 926 to the second major surface 918, so that the electrode 36B has a three-dimensional curved configuration. In some examples, the electrode 36B is a non-insulated portion of the metal (e.g., titanium) portion of the housing 912.

[0115] exist Fig. 10A In the example shown, the proximal electrode 36A is located on the first major surface 914 and is substantially flat and outward facing. However, in other examples, the proximal electrode 36A can utilize a three-dimensional curved configuration of the distal electrode 36B, thereby providing a three-dimensional proximal electrode (not shown in this example). Similarly, in other examples, the distal electrode 36B can utilize a substantially flat and outward facing electrode located on the first major surface 914, similar to the electrode shown with respect to the proximal electrode 36A.

[0116] Various electrode configurations allow for configurations in which the proximal electrode 36A and the distal electrode 36B are located on the first major surface 914 and the second major surface 918. In other configurations, such as Fig. 10AIn the configuration shown, only one of the proximal electrode 36A and the distal electrode 36B is located on both major surfaces 914 and 918, while in other configurations, both the proximal electrode 36A and the distal electrode 36B are located on one of the first major surface 914 or the second major surface 918 (i.e., the proximal electrode 36A is located on the first major surface 914, and the distal electrode 36B is located on the second major surface 918). In another example, the IMD 910A may include electrodes on major surfaces 914 and 918 at or near the proximal and distal ends of the device, such that a total of four electrodes are included on the IMD 910A. The electrodes 36A and 36B may be formed of a variety of different types of biocompatible conductive materials (e.g., stainless steel, titanium, platinum, iridium, or alloys thereof), and may utilize one or more coatings, such as titanium nitride or fractal titanium nitride.

[0117] exist Fig. 10A In the example shown, the proximal end 920 includes a head assembly 928 that includes one or more of the proximal electrode 36A, the integrated antenna 26A, the anti-migration protrusions 932, and / or the suture holes 934. The integrated antenna 26A is located on the same major surface (e.g., the first major surface 914) as the proximal electrode 36A and is also included as part of the head assembly 928. The integrated antenna 26A allows the IMD 910A to transmit and / or receive data. In other examples, the integrated antenna 26A may be formed on a major surface opposite the proximal electrode 36A, or may be incorporated into the housing 912 of the IMD 910A. Fig. 10A In the example shown, the anti-migration protrusion 932 is located adjacent to the integrated antenna 26A and protrudes away from the first major surface 914 to prevent longitudinal movement of the device. Fig. 10A In the example shown, the anti-migration protrusions 932 include a plurality (e.g., nine) of small bumps or protrusions extending away from the first major surface 914. As discussed above, in other examples, the anti-migration protrusions 932 may be located on the major surface opposite the proximal electrode 36A and / or the integrated antenna 26A. Fig. 10A In the example shown, head assembly 928 includes suture holes 934 that provide another means of securing IMD 910A to the patient to prevent movement after insertion. In the example shown, suture holes 934 are located near proximal electrode 36A. In one example, head assembly 928 is a molded head assembly made of a polymer or plastic material that can be integrated or separated from the main portion of IMD 910A.

[0118] Fig. 10B is a perspective view illustrating another IMD 910B, which may be an ICM from FIGS. 1 to 910B. Figure 3 Another example configuration of an IMD 10 (eg, IMD 10A). Fig. 10BThe IMD 910B can be basically similar to Fig. 10A The IMD 910A comes in two configurations, the differences between which are discussed in this article.

[0119] IMD 910B may include a leadless, subcutaneously implantable monitoring device, such as an ICM. IMD 910B includes a housing having a base 940 and an insulating cover 942. Proximal electrode 36C and distal electrode 36D may be formed or placed on an outer surface of cover 942. For example, regarding Figure 3 The various circuits and components of the described IMD 910B may be formed or placed on the inner surface of the cover 942 or within the base 940. In some examples, a battery or other power source for the IMD 910B may be included within the base 940. In the illustrated example, the antenna 26B is formed or placed on the outer surface of the cover 942, but in some examples, it may be formed or placed on the inner surface. In some examples, the insulating cover 942 may be positioned above the open base 940 so that the base 940 and the cover 942 enclose the circuits and other components and protect these circuits and other components from fluids such as body fluids. The housing including the base 940 and the insulating cover 942 may be hermetically sealed and configured for subcutaneous implantation.

[0120] Circuits and components may be formed on the inner side of the insulating cover 942, such as by using flip chip technology. The insulating cover 942 may be flipped onto the base 940. When flipped and placed onto the base 940, the components of the IMD 910B formed on the inner side of the insulating cover 942 may be positioned in the gap 944 defined by the base 940. Electrodes 36C and 36D and antenna 26B may be electrically connected to the circuit formed on the inner side of the insulating cover 942 by one or more through holes (not shown) formed through the insulating cover 942. The insulating cover 942 may be formed of sapphire (i.e., corundum), glass, poly-p-xylene, and / or any other suitable insulating material. The base 940 may be formed of titanium or any other suitable material (e.g., a biocompatible material). Electrodes 36C and 36D may be formed of any one of stainless steel, titanium, platinum, iridium, or their alloys. Among other things, electrodes 36C and 36D may be coated with a material such as titanium nitride or fractal titanium nitride, although other suitable materials and coatings for such electrodes may also be used.

[0121] exist Fig. 10B In the example shown, the housing of the IMD 910B defines a length L, a width W, and a thickness or depth D, and is in the form of an elongated rectangular prism, wherein the length L is much greater than the width W, which in turn is greater than the depth D, with Fig. 10A910A. For example, the spacing between the proximal electrode 36C and the distal electrode 36D may be in the range of 5mm to 50mm, 30mm to 50mm, 35mm to 45mm, and may be any single spacing or spacing range from 5mm to 50mm, such as about 40mm. In addition, the IMD 910B may have a length L ranging from 5mm to about 70mm. In other examples, the length L may be in the range of 30mm to 70mm, 40mm to 60mm, 45mm to 55mm, and may be any single length or length range from 5mm to 50mm, such as about 45mm. In addition, the width W may be in the range of 3mm to 15mm, 5mm to 15mm, 5mm to 10mm, and may be any single width or width range from 3mm to 15mm, such as about 8mm. The thickness or depth D of IMD 10B can be in the range of 2 mm to 15 mm, 5 mm to 15 mm, or 3 mm to 5 mm, and can be any single depth or depth range between 2 mm and 15 mm, such as about 4 mm. IMD 910B can have a volume of three cubic centimeters (cm) or less, or 1.5 cubic centimeters or less (such as about 1.4 cubic centimeters).

[0122] exist Fig. 10B In the example shown, once subcutaneously inserted into the patient's body, the outer surface of the cover 942 faces outward, toward the patient's skin. Fig. 10B As shown, proximal end 946 and distal end 948 are rounded to reduce discomfort and irritation to surrounding tissue once inserted under the patient's skin. Additionally, the edges of IMD 910B can be rounded.

[0123] The techniques described in this disclosure may be implemented at least in part in the form of hardware, software, firmware, or any combination thereof. For example, various aspects of these techniques may be implemented in one or more microprocessors, DSPs, ASICs, FPGAs, or any other equivalent integrated or discrete logic QRS circuits and any combination of such system-like components, which are embodied in external devices (such as physician or patient programmers, simulators, or other devices). The terms "processor" and "processing circuit" may generally refer to any of the aforementioned logic circuits, alone or in combination with other logic circuits, or any other equivalent circuit, alone or in combination with other digital or analog circuits.

[0124] For various aspects implemented in software, at least some of the functionality attributed to the systems and devices described in this disclosure may be embodied as instructions on a computer-readable storage medium, such as RAM, DRAM, SRAM, magnetic disk, optical disk, flash memory, or various forms of EPROM or EEPROM. The instructions may be executed to support one or more aspects of the functionality described in this disclosure.

[0125] In addition, in some aspects, the functions described herein can be set in dedicated hardware and / or software modules. Describing different features as modules or units is intended to highlight different functional aspects, and does not necessarily imply that such modules or units must be implemented by separate hardware or software components. On the contrary, the functions associated with one or more modules or units can be performed by separate hardware or software components, or integrated in common or separate hardware or software components. In addition, these techniques can be fully implemented in one or more circuits or logic elements. The technology disclosed herein can be implemented in various devices or equipment, including an IMD, an external programmer, a combination of an IMD and an external programmer, an integrated circuit (IC) or a group of ICs and / or discrete circuits residing in an IMD and / or an external programmer.

[0126] The following examples are illustrative of the techniques described herein.

[0127] Embodiment 1. A medical system, comprising: one or more medical devices configured to collect physiological parameter data of a patient, wherein the physiological parameter data includes impedance data corresponding to at least one fluid volume in the patient's body; and a processing circuit configured to: determine the dry impedance of the patient undergoing a dialysis treatment based on the physiological parameter data; and generate output data indicating the dry impedance for presentation to a clinician.

[0128] Embodiment 2. A medical system according to embodiment 1, wherein, to determine the dry impedance, the processing circuit is configured to: determine an estimate of the dry impedance based on impedance data collected in at least one case during or after a previous dialysis session; and compare the dry impedance with at least one of impedance data collected between the dialysis session and the previous dialysis session or impedance data collected during the dialysis session.

[0129] Embodiment 3. A medical system according to embodiment 1, wherein the processing circuit is configured to generate dialysis parameter data for controlling at least one of the dialysis treatment course or the next dialysis treatment course based on the dry impedance, wherein the dry impedance is established as a target for impedance data collected during the dialysis treatment course.

[0130] Embodiment 4. A medical system, comprising: one or more medical devices configured to collect physiological parameter data of a patient, wherein the physiological parameter data includes impedance data corresponding to at least one fluid volume in the patient's body; and a processing circuit configured to: determine the patient's risk level for receiving a dialysis treatment based on the physiological parameter data; and generate output data indicating the risk level for presentation to a clinician.

[0131] Embodiment 5. The medical system according to embodiment 4, wherein the processing circuit is configured to generate dialysis parameter data for controlling the dialysis treatment course based on at least one of the physiological parameter data or the risk level.

[0132] Embodiment 6. The medical system according to embodiment 5, wherein the physiological parameter data comprises physiological parameter data collected during the dialysis session, and the dialysis parameter data comprises updated dialysis parameter data.

[0133] Example 7. A medical system according to Example 5 or 6, wherein the dialysis parameter data includes the amount of fluid volume to be removed during the dialysis session.

[0134] Embodiment 8. A medical system according to any one or more of embodiments 5 to 7, wherein the dialysis parameter data comprises at least one of blood flow rate, fluid removal rate, ultrafiltration rate, duration of the dialysis session, or temperature.

[0135] Embodiment 9. The medical system according to any one or more of embodiments 4 to 8, wherein in order to determine the risk level, the processing circuit is configured to: determine the risk level of adverse effects occurring in the patient during the dialysis treatment.

[0136] Embodiment 10. The medical system according to any one or more of Embodiments 4 to 9, wherein to generate the output data, the processing circuit is configured to: generate the output data based on determining that the risk level meets at least one criterion.

[0137] Embodiment 11. A medical system according to any one or more of embodiments 4 to 10, wherein the physiological data includes physiological data collected during an interdialytic period between the dialysis treatment and a previous dialysis treatment, and the processing circuit is further configured to: determine an estimate of the dry impedance for the patient for the dialysis treatment based on the physiological parameter data.

[0138] Embodiment 12. A medical system according to embodiment 11, wherein the processing circuit is configured to perform at least one of the following: output the estimate of stem impedance for presentation to the clinician; or generate dialysis parameter data for controlling the dialysis treatment course based on the estimate of stem impedance.

[0139] Embodiment 13. The medical system of any one or more of Embodiments 4 to 12, wherein the processing circuit is configured to output the physiological parameter data for presentation to the clinician.

[0140] Example 14. A medical system according to any one or more of Examples 4 to 13, wherein the one or more medical devices are configured to collect impedance data at a first rate during an interdialytic period between the dialysis treatment and a previous dialysis treatment, and to collect impedance data at a second rate during an intradialytic period during the dialysis treatment.

[0141] Embodiment 15. The medical system of Embodiments 13 and 14, wherein the processing circuit is configured to output the physiological parameter data substantially continuously for presentation during the intra-dialytic period.

[0142] Embodiment 16. A medical system according to any one or more of Embodiments 4 to 15, wherein the impedance data for at least one fluid volume includes impedance measurements for at least one of an extravascular space, an intravascular space, or an interstitial space.

[0143] Embodiment 17. A medical system according to Embodiment 16, wherein the processing circuit is further configured to determine a net filtration rate based on impedance measurements of the interstitial space and impedance measurements of the intravascular space for at least one of an interdialytic period between the dialysis treatment and a previous dialysis treatment or an intradialytic period during the dialysis treatment.

[0144] Embodiment 18. The medical system of Embodiment 17, wherein the one or more medical devices include a first medical device configured to measure the impedance of the interstitial space and a second medical device configured to measure the impedance of the intravascular space.

[0145] Embodiment 19. The medical system of Embodiment 17 or 18, wherein the one or more medical devices include an insertable cardiac monitor configured to measure impedance of the interstitial space.

[0146] Embodiment 20. The medical system of Embodiment 16, wherein the processing circuit is further configured to determine a net filtration rate based on an impedance measurement of the interstitial space and the physiological parameter data of another physiological parameter indicative of a fluid volume in the intravascular space.

[0147] Embodiment 21. A medical system according to Embodiment 20, wherein the other physiological parameter comprises at least one of an electrocardiogram morphology parameter or a heart sound parameter.

[0148] Embodiment 22. A medical system according to any one of Embodiments 17 to 21, wherein the processing circuit is configured to perform at least one of the following: output the net filtration rate for presentation to the clinician; determine the risk level based on the net filtration rate; or generate dialysis parameter data for controlling the dialysis treatment course based on the net filtration rate.

[0149] Embodiment 23. A medical system according to any one of embodiments 1 to 22, wherein the physiological parameter data also includes electrocardiogram data, tachyarrhythmia data, heart sound data, activity data and posture data.

[0150] Embodiment 24. A method performed by a processing circuit of a medical system having one or more medical devices configured to collect physiological parameter data of a patient, the method comprising: determining a risk level of the patient for receiving a dialysis treatment based on the physiological parameter data, wherein the physiological parameter data includes impedance data corresponding to at least one fluid volume in the patient's body; and generating output data indicating the risk level for presentation to a clinician.

[0151] Embodiment 25. The method according to embodiment 24 further comprises: generating dialysis parameter data for controlling the dialysis treatment course based on at least one of the physiological parameter data or the risk level.

[0152] Embodiment 26. The method according to embodiment 24, wherein the physiological parameter data includes physiological parameter data collected during the dialysis session, and the dialysis parameter data includes updated dialysis parameter data.

[0153] Embodiment 27. The method according to embodiment 24 or 25, wherein the dialysis parameter data includes the amount of the fluid volume to be removed during the dialysis session.

[0154] Embodiment 28. The method according to any one or more of embodiments 25 to 27, wherein the dialysis parameter data includes at least one of fluid rate, ultrafiltration rate, or duration of the dialysis session.

[0155] Embodiment 29. The method according to any one or more of embodiments 24 to 28, wherein determining the risk level further comprises: determining the risk level of adverse effects occurring in the patient during the dialysis treatment.

[0156] Embodiment 30. A method according to any one or more of Embodiments 24 to 29, wherein generating the output data further comprises: generating the output data based on determining that the risk level satisfies at least one criterion.

[0157] Example 31. A method according to any one or more of Examples 24 to 30, wherein the physiological data includes physiological data collected during an interdialytic period between the dialysis treatment and a previous dialysis treatment, the method further comprising: determining an estimate of the dry impedance for the patient for the dialysis treatment based on the physiological parameter data.

[0158] Example 32. The method according to Example 31 further includes at least one of the following: outputting the estimate of trunk impedance for presentation to the clinician; or generating dialysis parameter data for controlling the dialysis treatment course based on the estimate of trunk impedance.

[0159] Embodiment 33. The method according to any one or more of embodiments 24 to 32 further comprises: outputting the physiological parameter data for presentation to the clinician.

[0160] Example 34. A method according to any one or more of Examples 24 to 33, wherein the one or more medical devices are configured to collect impedance data at a first rate during an interdialytic period between the dialysis treatment and a previous dialysis treatment, and to collect impedance data at a second rate during an intradialytic period during the dialysis treatment.

[0161] Embodiment 35. The method of Embodiment 33 or 34, further comprising: outputting the physiological parameter data substantially continuously for presentation during the intra-dialytic period.

[0162] Embodiment 36. The method of any one or more of claims 34 to 35, wherein the impedance data for at least one fluid volume comprises impedance measurements for at least one of an extravascular space, an intravascular space, or an interstitial space.

[0163] Embodiment 37. A method according to Embodiment 36, wherein the processing circuit is further configured to determine a net filtration rate based on impedance measurements of the interstitial space and impedance measurements of the intravascular space for at least one of an interdialytic period between the dialysis treatment and a previous dialysis treatment or an intradialytic period during the dialysis treatment.

[0164] Embodiment 38. The method of Embodiment 37, wherein the one or more medical devices include a first medical device configured to measure the impedance of the interstitial space and a second medical device configured to measure the impedance of the intravascular space.

[0165] Embodiment 39. The method of Embodiment 37 or 38, wherein the one or more medical devices include an insertable cardiac monitor configured to measure impedance of the interstitial space.

[0166] Embodiment 40. A method according to Embodiment 36, wherein the processing circuit is further configured to determine a net filtration rate based on an impedance measurement result for the interstitial space and the physiological parameter data indicating another physiological parameter of the fluid volume in the intravascular space.

[0167] Embodiment 41. A method according to Embodiment 40, wherein the other physiological parameter comprises at least one of an electrocardiogram morphology parameter or a heart sound parameter.

[0168] Example 42. A method according to any one of Examples 37 to 41, wherein the processing circuit is configured to perform at least one of the following: output the net filtration rate for presentation to the clinician; determine the risk level based on the net filtration rate; or generate dialysis parameter data for controlling the dialysis treatment based on the net filtration rate.

[0169] Embodiment 43. A method according to any one of embodiments 24 to 42, wherein the physiological parameter data also includes electrocardiogram data, rapid arrhythmia data, heart sound data, activity data and posture data.

[0170] Embodiment 44. A method comprising the steps performed by any of the medical systems described in embodiments 4 to 23.

[0171] Embodiment 45. A computing device configured to perform any of the methods described in embodiments 24 to 43.

[0172] Embodiment 46. A non-transitory computer-readable storage medium comprising program instructions which, when executed by a processing circuit of a medical system, cause the processing circuit to perform each step of any of the methods described in Embodiments 24 to 43.

Claims

1. A medical system, comprising: one or more medical devices configured to collect physiological parameter data of a patient, wherein the physiological parameter data includes impedance data corresponding to at least one fluid volume in the patient; and A processing circuit, the processing circuit being configured to: determining a stem impedance of the patient undergoing a dialysis session based on the physiological parameter data; as well as Output data indicative of the trunk impedance is generated for presentation to a clinician.

2. The medical system of claim 1 , wherein to determine the trunk impedance, the processing circuit is configured to: determining an estimate of the stem impedance based on impedance data collected on at least one occasion during or after a previous dialysis session; and The dry impedance is compared to at least one of impedance data collected between the dialysis session and the previous dialysis session or impedance data collected during the dialysis session.

3. A medical system according to claim 1 or 2, wherein the processing circuit is configured to generate dialysis parameter data for controlling at least one of the dialysis treatment course or the next dialysis treatment course based on the dry impedance, wherein the dry impedance is established as a target for impedance data collected during the dialysis treatment course.

4. The medical system according to any one or more of claims 1 to 3, wherein the processing circuit is configured to: Determining a risk level for the patient to undergo a dialysis treatment course based on the physiological parameter data; and Output data indicative of the risk level is generated for presentation to the clinician.

5. The medical system of claim 4, wherein the processing circuit is configured to generate dialysis parameter data for controlling the dialysis session based on the risk level.

6. The medical system of claim 5, wherein the physiological parameter data comprises physiological parameter data collected during the dialysis session, and the dialysis parameter data comprises updated dialysis parameter data.

7. A medical system according to claim 5 or 6, wherein the dialysis parameter data includes the amount of the fluid volume to be removed in the dialysis session.

8. A medical system according to any one or more of claims 5 to 7, wherein the dialysis parameter data includes at least one of blood flow rate, fluid removal rate, ultrafiltration rate, duration of the dialysis session, or temperature.

9. The medical system of any one or more of claims 4 to 8, wherein to determine the risk level, the processing circuit is configured to: A risk level of an adverse effect occurring in said patient during said dialysis treatment is determined.

10. The medical system according to any one or more of claims 4 to 9, wherein, in order to generate the output data, the processing circuit is configured to: The output data is generated based on determining that the risk level satisfies at least one criterion.

11. A medical system according to any one or more of claims 1 to 10, wherein the one or more medical devices are configured to collect impedance data at a first rate during an interdialytic period between the dialysis session and a previous dialysis session, and to collect impedance data at a second rate during an intradialytic period during the dialysis session.

12. The medical system of any one or more of claims 1 to 11, wherein the impedance data for at least one fluid volume comprises impedance measurements for at least two of an extravascular space, an intravascular space, or an interstitial space.

13. The medical system of claim 12, wherein the processing circuit is further configured to: A net filtration rate is determined based on impedance measurements of the interstitial space and impedance measurements of the intravascular space for at least one of an interdialytic period between the dialysis session and a previous dialysis session or an intradialytic period during the dialysis session.

14. The medical system of claim 12 or 13, wherein the one or more medical devices include a first medical device configured to measure impedance of the interstitial space and a second medical device configured to measure impedance of the intravascular space.

15. The medical system of claim 14, wherein the first medical device comprises an insertable cardiac monitor configured to measure impedance of the interstitial space.

16. The medical system of claim 15, wherein the insertable cardiac monitor comprises: a housing configured for subcutaneous implantation in the patient, the housing having a length between 40 millimeters (mm) and 60 mm, a width less than the length, and a depth less than the width between a first end and a second end; a first electrode located at or near the first end; and a second electrode, the second electrode being located at or near the second end, Wherein the insertable cardiac monitor is configured to measure impedance of the interstitial space via the first electrode and the second electrode.

17. The medical system of any one or more of claims 12 to 16, wherein the processing circuit is further configured to: A net filtration rate is determined based on an impedance measurement of the interstitial space and the physiological parameter data indicative of another physiological parameter of fluid volume in the intravascular space.

18. The medical system of claim 17, wherein the another physiological parameter comprises at least one of an electrocardiogram morphology parameter or a heart sound parameter.

19. The medical system of any one or more of claims 1 to 18, wherein the physiological parameter data further comprises electrocardiogram data, tachyarrhythmia data, heart sound data, activity data and posture data.